Trinity Life Sciences
Fostering Data-Driven Decisions in the Life Sciences

Trinity Life Sciences is a prominent player in the life sciences industry, offering various integrated, evidence-based solutions tailored for life sciences companies. With nearly 30 years of expertise, the company combines strategy, insights, and analytics to assist life science executives in making informed clinical and commercial decisions. It guides pharmaceutical, biotech, and medical device companies through the intricate processes of drug and device development, market optimization, and commercialization.

The company serves over 300 pharmaceutical, biotech and medical device clients, helping them develop and optimize drugs and devices for the market. In 2023, Trinity Life Sciences worked on 75 percent of all new drug launches. With a global presence of over 1,200 professionals across 11 strategic offices in the U.S., Europe, and Asia, the firm combines deep industry knowledge with cutting-edge technology to empower clients in bringing transformative therapies to patients.

“With our nearly 30-year history of offering evidence-based solutions and our commitment to a greater purpose, there is no better partner to successfully see your drug through from molecule to market and beyond,” says Leslie Orne, President, CEO and Board Member at Trinity Life Sciences.

Founded in 1996 as Trinity Partners, the firm has grown organically and through acquisitions, including BluePrint Research Group, CBPartners, TGaS Advisors, Bell Canyon, and D Cube Analytics. The company has also formed a transformative partnership with Bain & Company to advance its mission of revolutionizing the pharmaceutical commercial model.

A pivotal alliance with Bain & Company further exemplifies the firm’s commitment to transforming the pharmaceutical commercial model. It blends Bain's renowned expertise in transformational change with Trinity Life Sciences’ specialized market knowledge and sophisticated analytical solutions. This collaboration enhances the firm’s ability to provide integrated, end-to-end support for clients navigating complex market dynamics. Demonstrating its sustained growth and industry prominence, Trinity Life Sciences secured its fourth consecutive placement on the Inc. 5000 list in August 2024, solidifying its status as one of the fastest-growing private companies in America.

The company distinguishes itself through a meticulously structured, three-tiered service architecture that integrates advisory services, insights and analytics, and advanced technology. These solutions are precisely engineered to address the multifaceted needs of well-established pharmaceutical giants and emerging biotech innovators. Its core competencies span various specialized areas, including primary market research, strategic consulting, valuation services, and advanced analytics, ensuring a holistic approach to client support.

With our nearly 30-year history of offering evidence-based solutions and our commitment to a greater purpose, there is no better partner to successfully see your drug through from molecule to market and beyond

Trinity Life Sciences is also committed to exceeding client expectations, fostered through a deeply ingrained culture of excellence. The company champions diverse perspectives and talents, cultivating an equitable and inclusive workplace where every team member is valued and respected. It promotes intellectual curiosity, mentorship opportunities, and a proactive approach to challenging conventional norms. Guided by core principles of empathy, integrity, and mutual respect, Trinity Life Sciences ensures seamless collaboration and the delivery of superior-quality solutions. Encouraging authenticity and prioritizing teamwork fosters an environment where innovation and excellence thrive.

Trinity Life Sciences functions as a strategic linchpin within the life sciences industry, offering a comprehensive suite of services that spans from high-level strategic advisory to transformative technological innovation. The firm’s steadfast dedication to evidence-based methodologies and its resolute focus on fostering a culture of innovation and inclusivity establish it as a crucial enabler for pharmaceutical and biotech companies. The company enhances commercial success by helping organizations navigate market complexities and facilitating the delivery of impactful therapies to patients worldwide. It significantly contributes to the advancement of global healthcare outcomes.